NU50CK000645
Cooperative Agreement
Overview
Grant Description
Emerging Infections Program - Georgia Emerging Infections Program project abstract summary. The objective of CDC's Emerging Infections Program (EIP) and the goal of the Georgia (GA) EIP application is to perform active, population-based surveillance and related studies that will improve the capacity to prevent, control, and monitor the public health impact of established and emerging infectious diseases.
Georgia Department of Public Health (GDPH) along with Emory University and other partners, will conduct surveillance and special studies for the following categories of infections: enteric (FoodNet), invasive bacterial (ABCs), fungal (candidemia, mold, endemic mycoses), respiratory viral infections (influenza, RSV, COVID-19), MPOX and healthcare-associated infections. The GA EIP proposal also includes core infrastructure activities including training, enhancements in information technology, informatics, biostatistics, and leadership/cross-cutting activities.
The outcomes will include improved surveillance and response capacity, improved capacity to recognize, control, and prevent infectious disease outbreaks, and decreased burden and severity of infectious diseases.
Georgia Department of Public Health (GDPH) along with Emory University and other partners, will conduct surveillance and special studies for the following categories of infections: enteric (FoodNet), invasive bacterial (ABCs), fungal (candidemia, mold, endemic mycoses), respiratory viral infections (influenza, RSV, COVID-19), MPOX and healthcare-associated infections. The GA EIP proposal also includes core infrastructure activities including training, enhancements in information technology, informatics, biostatistics, and leadership/cross-cutting activities.
The outcomes will include improved surveillance and response capacity, improved capacity to recognize, control, and prevent infectious disease outbreaks, and decreased burden and severity of infectious diseases.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Georgia
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 138541% from $20,000 to $27,728,165.
Georgia Department Of Public Health was awarded
Georgia EIP: Enhancing Infectious Disease Surveillance and Response
Cooperative Agreement NU50CK000645
worth $27,728,165
from National Center for Immunization and Respiratory Diseases in January 2024 with work to be completed primarily in Georgia United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.185 Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects.
The Cooperative Agreement was awarded through grant opportunity Emerging Infections Program.
Status
(Ongoing)
Last Modified 9/5/25
Period of Performance
1/1/24
Start Date
12/31/28
End Date
Funding Split
$27.7M
Federal Obligation
$0.0
Non-Federal Obligation
$27.7M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU50CK000645
Additional Detail
Award ID FAIN
NU50CK000645
SAI Number
NU50CK000645-973080220
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVG0 CDC NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES
Awardee UEI
GUT1BFELPFJ1
Awardee CAGE
6DZR5
Performance District
GA-90
Senators
Jon Ossoff
Raphael Warnock
Raphael Warnock
Modified: 9/5/25